In the article “Treatment Satisfaction, Product Perception, and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05%” by Fowler et al, published in the November 2017 edition of JCAD [J Clin Aesthet Dermatol. 2017;10(11):13–18], it has been brought to the attention of the publisher that incorrect versions of Figures 1 and 2 were inadvertently submitted to the journal. In the corrected versions (included below), a “%” symbol has been deleted from the Y axis labels of Figures 1A–D and the Day 14 (BSA >10%) column value has been changed from “82.0” to “83.0” in Figure 2C. The legend wording for both figures has also been revised (changes in yellow). The authors regret the error.
FIGURE 1.
Change from baseline in A) Investigators Global Assessment (IGA) score; B) Total Sign Score (TSS); C) quality of life as measured by the Dermatology Life Quality Index (DLQI) and; D) percentage body surface area (BSA) involvement
FIGURE 2.
Treatment satisfaction scores for A) Effectiveness; B) Side Effects; C) Global Satisfaction; and D) Convenience